NCAP Annual Convention 2018 - Positioning for Influence: from Patient Stories to Pharmacy Vision Poster Session Abstracts Category: Original Research Title: A Retrospective Review of Factors that Impact Performance in a Year-Long Top 200 Drug Course Authors: Sophia DeBerry, Cortney Mospan, PharmD, BCACP, BCGP; Christopher Gillette, PhD Objectives: To assess the impact of pre-requisite GPA, semester that Introductory Pharmacy Practice Experience (IPPE) occurred, IPPE practice location, completion of practice quizzes (PQs), and campus attended on student performance in a Top 200 Drug course. Methods: A retrospective observational analysis of performance in a Top 200 course was completed. Students were included if they were enrolled in both semesters of the course and completed their Community IPPE in 2016 -2017. Linear regression models were created to examine how pre-requisite GPA, semester that IPPE occurred, type of IPPE site, completion of >80% of practice quizzes, and campus location were associated with final course grade in both semesters. Results: Students were significantly more likely to have higher fall final course grades when they had a higher pre-requisite GPA (b=8.75, p<0.0001), were enrolled in IPPE (b=2.81, p=0.034), and completed >80% of PQs (b=4.15, p=0.005). Students who had higher pre-requisite GPAs (b=3.75, p=0.03), completed >80% of PQs (b=3.47, p=0.002), attended the satellite campus (b=-3.22, p=0.009), had completed IPPE at a grocery store or mass merchant (b=2.63, p=0.026), and had higher scores in the fall semester (b=0.35, p<0.0001) had higher spring course grades. Conclusion: Several factors were identified that impacted student performance, some of which may not be expected. Students with a higher pre-requisite GPA and those who completed >80% of PQs performed better. Campus location and IPPE location also impacted student performance. Further investigations should assess how these factors improved student performance and if they can impact student performance in other courses. Category: Original Research Title: Implementation and Evaluation of a Pharmacist-led Hypertension Management Clinic Authors: Andrew P. Clark, PharmD, BCPS, CDE, CPP; North Carolina Pharmacist
Page 24
Kristie D. Clark, PharmD, CDE, CPP; Nick Wilkins, PharmD, BCPS, CDE, CPP Institution: Carolinas HealthCare System NorthEast – Concord Internal Medicine Objective: The primary objective was to assess the impact of pharmacist intervention on patients with hypertension. Secondary outcomes included systolic and diastolic blood pressure values and medication interventions including the number and type of medication-related problem interventions and percentage resolved by the clinical pharmacist, and average number of antihypertensive medications at three months after the last pharmacist office visit. Methods: Medical records of 106 patients with hypertension from January 1, 2017 to December 31, 2017 were reviewed. Patients were included in the blood pressure outcome data if they had an office visit with the pharmacist at least once, and had at least one documented blood pressure at any visit three months after the last pharmacist visit. Medication-related problems were reported for all patients seen in 2017. Results: 78 patients met criteria and were included in the analysis. The average systolic blood pressure in the study group improved from 145.5 mmHg to 140.4 mmHg (p < 0.0417) and the average diastolic blood pressure improved from 81.5 mmHg to 77.7 mmHg (p < 0.0210). 52.6% of patients met their age specific goals three months after meeting with the pharmacist, compared with 35.9% before intervention. Pharmacists made a total of 141 medication-related problem recommendations, of which 133 recommendations were implemented by the pharmacist. A total of 106 unique patients were seen for 153 visits by pharmacists in 2017. Patients did not take significantly more antihypertensive medications on average after meeting with the pharmacist – 2.14 medications per patient initially versus 2.31 medications on average at three months. Conclusion: Patients who were seen by a clinical pharmacist at least once showed a statistically significant improvement in systolic and diastolic blood pressures. A greater percentage of patients achieved their age-appropriate BP goals without significantly increasing medication burden. Category: Original Research Volume 99 Number 3 Summer 2018
